Terms: = Colorectal cancer AND PDGFRA, MGC74795, 5156, ENSG00000134853, PDGFR2, CD140A, Rhe-PDGFRA, CD140a, P16234 AND Prognosis
10 results:
1. Identification of a novel lymphangiogenesis signature associated with immune cell infiltration in colorectal cancer based on bioinformatics analysis.
Liu H; Shi H; Sun Y
BMC Med Genomics; 2024 Jan; 17(1):2. PubMed ID: 38167072
[TBL] [Abstract] [Full Text] [Related]
2. Site specific genetic differences in colorectal cancer via Next-Generation-Sequencing using a multigene panel.
Rencuzogullari A; Bisgin A; Erdogan KE; Gumus S; Yalav O; Boga I; Sonmezler O; Eray IC
Ann Ital Chir; 2023; 94():605-611. PubMed ID: 38131395
[TBL] [Abstract] [Full Text] [Related]
3. A Risk Model for prognosis and Treatment Response Prediction in Colon Adenocarcinoma Based on Genes Associated with the Characteristics of the Epithelial-Mesenchymal Transition.
Huang H; Li T; Meng Z; Zhang X; Jiang S; Suo M; Li N
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686013
[TBL] [Abstract] [Full Text] [Related]
4. Multiple primary malignances managed with surgical excision: a case report with next generation sequencing analysis.
Romano C; Di Gregorio S; Pennisi MS; Tirrò E; Broggi G; Caltabiano R; Manzella L; Ruggieri M; Vigneri P; Di Cataldo A
Mol Biol Rep; 2022 Sep; 49(9):9059-9064. PubMed ID: 35715605
[TBL] [Abstract] [Full Text] [Related]
5. Dysregulated PDGFR alpha expression and novel somatic mutations in colorectal cancer: association to RAS wild type status and tumor size.
Ben Jemii N; Tounsi-Kettiti H; Yaiche H; Mezghanni N; Jaballah Gabteni A; Fehri E; Ben Fayala C; Abdelhak S; Boubaker S
J Transl Med; 2020 Nov; 18(1):440. PubMed ID: 33213472
[TBL] [Abstract] [Full Text] [Related]
6. PAI1 is a Marker of Bad prognosis in Rectal cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208.
Muñoz-Galván S; Rivero M; Peinado-Serrano J; Martinez-Pérez J; Fernández-Fernández MC; Ortiz MJ; García-Heredia JM; Carnero A
Cells; 2020 Apr; 9(5):. PubMed ID: 32344898
[TBL] [Abstract] [Full Text] [Related]
7. The Clinicopathological and Survival Profiles Comparison Across Primary Sites in Acral Melanoma.
Wei X; Wu D; Li H; Zhang R; Chen Y; Yao H; Chi Z; Sheng X; Cui C; Bai X; Qi Z; Li K; Lan S; Chen L; Guo R; Yao X; Mao L; Lian B; Kong Y; Dai J; Tang B; Yan X; Wang X; Li S; Zhou L; Balch CM; Si L; Guo J
Ann Surg Oncol; 2020 Sep; 27(9):3478-3485. PubMed ID: 32253677
[TBL] [Abstract] [Full Text] [Related]
8. Gene mutation profiling in Chinese colorectal cancer patients and its association with clinicopathological characteristics and prognosis.
Ye ZL; Qiu MZ; Tang T; Wang F; Zhou YX; Lei MJ; Guan WL; He CY
Cancer Med; 2020 Jan; 9(2):745-756. PubMed ID: 31782259
[TBL] [Abstract] [Full Text] [Related]
9. Mutation profiling in chinese patients with metastatic colorectal cancer and its correlation with clinicopathological features and anti-EGFR treatment response.
Li ZZ; Wang F; Zhang ZC; Wang F; Zhao Q; Zhang DS; Wang FH; Wang ZQ; Luo HY; He MM; Wang DS; Jin Y; Ren C; Qiu MZ; Ren J; Pan ZZ; Li YH; Shao JY; Xu RH
Oncotarget; 2016 May; 7(19):28356-68. PubMed ID: 27050078
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathologic factors predicting outcomes in patients with gastrointestinal stromal tumors of the rectum and colon.
Zhou Z; Chen Z; Chen M; Wang R; Yin Y; Yao Y
Tumour Biol; 2014 May; 35(5):4357-62. PubMed ID: 24375257
[TBL] [Abstract] [Full Text] [Related]
